Trial Profile
A Randomized, Single-Blind, Active-Controlled, Dose-Ranging Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing Total Knee Arthroplasty
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2020
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Haemorrhage
- Focus Pharmacokinetics
- Sponsors Pacira BioSciences
- 11 Dec 2017 Status changed from recruiting to discontinued.
- 12 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Jun 2018.
- 12 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Mar 2018.